Navigation Links
Inflammation in Biological Technology

Omeros Appoints New Vice President of Clinical Development

... several preclinical central nervous system and inflammation programs that have the potential to address ... and commercializing products focused on inflammation and disorders of the central nervous system. ... pipeline of preclinical programs targeting inflammation and central nervous system disorders. For more ...

Intellikine Completes $51 Million Financing

... small molecule drugs for the treatment of cancer, inflammation and autoimmune diseases, announced today that it ... (PI3K) pathway for the treatment of cancer, inflammation and autoimmune diseases. The company has ... PI3K/mTOR pathway for the treatment of cancer, inflammation and autoimmune diseases. Intellikine has ...

DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation

... dipropionate or BDP) decreases non-infectious inflammation of the lung in acute gastrointestinal ... cell transplants (HCT). Non-infectious inflammation of the lung is a common and potentially fatal ... event reports of infectious and non-infectious inflammation of the lung. These observations by Dr. ...

Resverlogix's Success in Inflammation Program Results in 2 Patents Filed

... proprietary molecules markedly reduced inflammation while improving mobility of arthritic animals. ... to examine the various disease indications in inflammation which would have the greatest potential impact ... effective and economical therapies for specific inflammation markets. For example, a small molecular drug for ...

VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients

... of Action and Positive Impact on Vascular inflammation SAN FRANCISCO, May 14 ... study examines the impact of VIA-2291 on plaque inflammation as measured by Positron Emission Tomography with ... of leukotrienes, which are important mediators of inflammation believed to be involved in the development and ...

Recombinant C-Reactive Protein

... its presence indicates an increased state of inflammation in the body. inflammation is a normal response to a number of physical states including injury, fever and infection. inflammation is also believed to play a role in the initiation ...

First oral uveitis drug reduces both inflammation and recurrence in potentially blinding eye disease

... Fort Lauderdale, FL (May 4, 2009): Uveitis, or inflammation within the eye, is a group of diseases ... of autoimmune diseases characterized by chronic inflammation of the eye, is the 4th leading cause of blindness ... corticosteroids used commonly to keep chronic inflammation within the eye under control is in the range of ...

Sirion Therapeutics Supplemental New Drug Application for Durezol(TM) to Treat Uveitis is Accepted for Review by the FDA

... in June 2008 for the treatment of post-operative inflammation and pain associated with ocular surgery. ... a disease state in which prompt eradication of inflammation is key in preserving vision," stated Roger Vogel, ... NDA. About Uveitis Uveitis is inflammation of the middle three layers of the eye: iris, ...

VIA Pharmaceuticals Announces Grant of New Patent on Lead Compound VIA-2291

... disease caused by atherosclerosis, targets inflammation in the blood vessel wall, an underlying cause of ... VIA-2291 clinical program points to reduction of inflammation and inflammatory processes in the vessel wall as ... a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying ...

Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice

... PF4 and RANTES is a novel approach to targeting inflammation that may lead to a new class of medications for ... immune system) to the arterial wall, causing the inflammation that is characteristic of atherosclerosis. ... a high fat diet did not develop chronic arterial inflammation when injected with the mouse version of the CKEY2 ...

Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH

... with undiagnosed blood clots and inflammation in patients with PNH. A separate study ... Blood Markers of Thrombin Generation and inflammation Research titled "Eculizumab Therapy ... in Markers of Thrombin Generation and inflammation in Patients with PNH" was presented yesterday in ...

Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models

... arthritis through its inhibitory activity on inflammation and angiogenesis." Kenneth W. Bair, Ph.D., ... arthritis, is a systemic disease characterized by inflammation of the membrane lining of the joint, which causes ... cell cycle regulation, cell signaling and inflammation - processes vital to the treatment of cancer and ...

Omeros Appoints David A. Mann to its Board of Directors

... David Mann. "With a deep pipeline focused on inflammation and CNS, Omeros represents an exciting ... and commercializing products focused on inflammation and disorders of the central nervous system. ... pipeline of preclinical programs targeting inflammation and central nervous system disorders. For more ...

Xceed Molecular to Launch New Inflammation Xpress Chip(TM)for the Ziplex(R) Automated Gene-Expression Analysis System at Clinical Lab Expo 2008, Booth 2155

... analysis systems, will launch its new inflammation Xpress Chip, a pre-configured array for use with ... and other immuno-regulatory factors. Our inflammation Xpress Chip is a powerful tool to enable ... in specific genes and pathways represented on the inflammation Xpress Chip may help in monitoring ...

Sirion Therapeutics Announces FDA Approval of Durezol(TM) for Treatment of Postoperative Ocular Inflammation and Pain

... Durezol is First Ophthalmic Steroid Indicated for inflammation and Pain TAMPA, Fla., June 24 /PRNewswire/ -- ... that having access to a steroid that treats both inflammation and pain gives physicians a more complete ... patients diagnosed with significant postoperative inflammation (more than 10 anterior chamber cells), Durezol ...

Interleukin Genetics to Present at the 13th International Conference on Periodontal Research

... Dr. Kenneth Kornman to Discuss Periodontal inflammation and Gene-Environment ... and environmental factors that control inflammation differences among individuals. The ICPR meeting ... products to prevent or treat diseases of inflammation and other genetic variations, our ability ...

Pharmaxis' Aridol Authorised for Sale in Germany

... a local distributor. A simple-to-use airways inflammation test, Aridol is a dry powder administered to ... determine the severity of a patient's airways inflammation -- a hallmark of asthma -- and allow prescription ... patient's asthma. People without airway inflammation do not respond to an Aridol challenge test. ...

Depth of MedImmune's Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society

... Tony Coyle, vice president, head, autoimmunity inflammation and respiratory disease research. "We are pleased ... to be presented includes: -- Regulation of Lung inflammation in Animal Models (Poster Session: IL-33, the ... Flying High (Symposium: Hyperresponsiveness and inflammation in a Murine Model of Asthma, publication page ...

JCI table of contents: April 22, 2008

... defining a molecular pathway that promotes inflammation and tumor development in the stomach ... bacterium Helicobacter pylori leads to persistent inflammation of the stomach lining and in some individuals ... and signaling pathways that might promote inflammation and tumor development in the stomach has been ...

Ocular Biopharmaceutical Company Charlesson Announces $1.6MM in New Funding and Upcoming Presentations at The Association for Research in Vision and Ophthalmology

... retinal disease. "Our core philosophy is that inflammation and vascular leakage in the retina are early ... forms of retinal disease. Inhibition of retinal inflammation and vascular leakage has thus become a new target ... in the eye. Recent evidence suggests that inflammation is also a key pathogenic feature of AMD. ...

Vasogen Announces Implementation of Strategic Restructuring Plan

... impressed with their ability to reduce markers of inflammation and improve outcome measures across a number ... models. The understanding of the role of inflammation in a wide range of human diseases continues to ... and treatments that regulate different aspects of inflammation have become a key focus for ...

Sirion Therapeutics Highlights Pivotal Trial Results of Durezol(TM) at the American Society of Cataract and Refractive Surgery Annual Symposium

... each year in the United States. Post-operative inflammation is a common occurrence following these ... and/or NSAID drops to prevent it. Most often, inflammation lasts a relatively short time, though severe ... a topical steroid for post-operative inflammation and uveitis; ganciclovir, a topical antiviral for ...

Aridol(TM) Endorsed by International Olympic Committee

... induced asthma. A simple-to-use airways inflammation test, Aridol is a dry powder administered to ... determine the severity of a patient's airways inflammation C a hallmark of asthma -and allow prescription of ... patient's asthma. People without airway inflammation do not respond to an Aridol challenge test. ...

Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management

... Physician's office system for measuring airway inflammation poised to transform asthma management ... which is a well-established indicator of airway inflammation and asthma control. The Insight system is a ... tool to measure their patients' respiratory inflammation better than ever before. Measurement of eNO has ...

FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma

... Disease Management through Personalized inflammation Control NEW PROVIDENCE, N.J., March 4 ... is the first hand-held device to measure airway inflammation -- an underlying cause of inflammatory airway ... about this is that the control of airway inflammation is the key to the successful management of ...

Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure

... About Celacade: The Celacade System targets the inflammation underlying chronic heart failure and other cardiovascular diseases. inflammation is a normal response of the immune system to ... - potent chemical messengers that modulate inflammation and facilitate the healing process. While this ...

JCI table of contents: Dec. 3, 2007

... allergic responses in mice with TSLP-induced inflammation of the lungs or skin and in mice with chronic or ... thymic stromal lymphopoietin driven atopic inflammation AUTHOR CONTACT: Flavius Martin Genentech ... of platelet precursor cells Infection and inflammation are sometimes accompanied by an excess of ...

Prometheus Licenses COLAL-PRED(R) From Alizyme

... (IBD), the general name for disease that causes inflammation in the small intestine and colon. Ulcerative ... disease. Ulcerative colitis is marked by inflammation and ulceration of the innermost lining of the colon. Crohn's disease differs because it causes inflammation deeper within the intestinal wall and can occur ...

VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease

... VIA-2291, is a small molecule drug that targets inflammation in the blood vessel wall, a primary disease ... of leukotrienes (important mediators of inflammation involved in the development and progression of ... developed as a once-daily, oral drug to target inflammation in the blood vessel wall, thereby potentially ...

Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results

... mixture and a grape vine extract, reduced inflammation more effectively in individuals with genetic ... that are associated with over-expression of inflammation and risk for early heart attacks. -- The Company ... products to prevent or treat diseases of inflammation and other genetic variations, our ability ...

VIA Pharmaceuticals' Lead Compound, VIA-2291, Chosen as a Top Ten Most Licensable Cardiovascular Program for Windhover Information's Therapeutic Area Partnerships Conference

... VIA-2291, is a small molecule drug that targets inflammation in the blood vessel wall, a primary disease ... of leukotrienes (important mediators of inflammation involved in the development and progression of ... developed as a once-daily, oral drug to target inflammation in the blood vessel wall, thereby potentially ...

Vasogen Announces Third Quarter 2007 Results

... who discussed the importance of the role inflammation plays in the development and progression of ... how the growing understanding of the role inflammation in heart failure has led to new treatment ... are consistent with the role that chronic inflammation plays in the development and progression of HF ...

Micromet Closes $80.5 Million Public Offering of Common Stock

... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the closing of its previously ... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel ...

Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab

... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it has received Orphan Drug ... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel ...

Micromet Announces Pricing of Public Offering of Common Stock

... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the pricing of its public ... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel ...

Micromet Announces Public Offering of Common Stock

... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it intends to offer shares ... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel ...

Micromet, Inc. to Host Conference Call and Webcast to Report Second Quarter 2009 Financial Results on August 6, 2009

... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it will host a conference ... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel ...

Micromet Added to Russell 3000 Index

... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it was added to the Russell ... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel ...

Micromet to Host Conference Call and Webcast to Discuss Blinatumomab Data Presented at EHA on June 8, 2009

... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it will host a webcast on ... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel ...

Micromet Presents Update at ASCO 2009 on a Phase 1b Combination Study of Adecatumumab and Docetaxel

... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, presented data from a clinical trial ... developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel ...
Other Contents
(Date:7/13/2015)... SAN JOSE, Calif. , July 13, 2015 ... the leading developer of human interface solutions, today ... second generation touch and display driver integration (TDDI) ... solution is the first to combine Synaptics , ... expertise with proven display driver technology developed in ...
(Date:7/9/2015)... 9, 2015  Unchained Labs just can,t get ... of Avid Nano. Avid Nano designs, develops and ... Also today, Unchained Labs UNcaged ... to use protein sizing system. The pUNk is ... hydrodynamic size, size distribution, aggregation population and molecular ...
(Date:7/8/2015)... DIEGO , July 8, 2015  Trovagene, ... cell-free molecular diagnostics, today announced the launch of ... the Company,s Precision Cancer Monitoring℠ (PCM) technology for ... receiving one or a combination of the novel ... Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient study ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Several years ... population of children with autism, Little City took a proactive stance and began planning ... The Coleman Foundation grant provides valuable support to building the third home. , “We ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... a “forward thinker.” Since the late 1970s, Dr. Cottrell has been making predictions ... book, The New Earth, documents many of these prognostications. He warns that extreme ...
(Date:7/29/2015)... ... July 29, 2015 , ... National non-profit World T.E.A.M. Sports ... annuities, employee benefits and asset management, has joined as presenting sponsor for the ... in Charlotte, North Carolina on October 2-4, 2015. , Hosted at the ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... seeking funding for a study on the potentially lifesaving impact of removing aluminum ... . , The research proposal is based on a successful pilot study ...
(Date:7/29/2015)... ... July 29, 2015 , ... One may not expect to encounter ... facility, but that’s exactly what was happening on the campus of Piedmont Crossing ... and 4-year-olds from Kids Only , a five-star childcare center which operates on ...
Breaking Medicine News(10 mins):Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4
Other TagsOther Tags